When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. UVA pain research suggests new ways to manage migraine ... - AOL

   www.aol.com/uva-pain-research-suggests-ways...

   The researchers say their new understanding of the complex relationship between pain and progesterone and its receptors could pave the way for new ways to treat and manage chronic pain and ...

3. Migraines are getting worse — and climate change could be ...

   www.aol.com/news/migraines-getting-worse-climate...

   Researchers found the prevalence of migraines in the past three decades has remained stable, but found Migraine Disability Assessment Scale scores, which measure how migraines affect a person ...

4. New Startups and Innovations Are Starting To Give Migraine ...

   www.aol.com/startups-innovations-starting...

   Despite the prevalence of the illness, there are only about 500 headache specialists in the United States, and there’s been a lack of funding for research into causes and treatment, according to ...

5. Management of migraine - Wikipedia

   en.wikipedia.org/wiki/Management_of_migraine

   Rescue treatment involves acute symptomatic control with medication. [4] Recommendations for rescue therapy of migraine include: (1) migraine-specific agents such as triptans, CGRP antagonists, or ditans for patients with severe headaches or for headaches that respond poorly to analgesics, (2) non-oral (typically nasal or injection) route of administration for patients with vomiting, (3) avoid ...

6. Management of chronic headaches - Wikipedia

   en.wikipedia.org/wiki/Management_of_chronic...

   Multiple sources recommend multimodal treatment, which is a combination of medicinal and non-medicinal remedies. [5] Some treatments are controversial and are still being tested for effectiveness. Suggested treatments for chronic headaches include medication, physical therapy, acupuncture, relaxation training, and biofeedback.

7. Antimigraine drug - Wikipedia

   en.wikipedia.org/wiki/Antimigraine_drug

   Erenumab is a highly selective human monoclonal antibody which is a promising new development in migraine treatment. [14] It has low risk of hepatoxicity like gepants can have, due to being mostly eliminated via proteolysis.